Resolvin E1 maintains macrophage function under cigarette smoke-induced oxidative stress

FEBS Open Bio

Volumn 2, Issue , 2012, Pages 328-333

  Takamiya, Rina ^a,b,c   Fukunaga, Koichi ^b   Arita, Makoto ^d   Miyata, Jun ^b   Seki, Hiroyuki ^a   Minematsu, Naoto ^b   Suematsu, Makoto ^b   Asano, Koichiro ^b,e  

^a KEIO UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c RIKEN   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cigarette smoke; Macrophage; Reactive oxygen species; Resolvin E1

Indexed keywords

CIGARETTE SMOKE; ICOSAPENTAENOIC ACID; RESOLVIN E1; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LINE; CELL MEMBRANE; MACROPHAGE; METABOLITE; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 84867685794     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2012.10.001     Document Type: Article

References (37)

1. Barnes P.J. Chronic obstructive pulmonary disease. N. Engl. J. Med. 2000, 343:269-280.
2. Pryor W.A., Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann. N.Y. Acad. Sci. 1993, 686:12-27. discussion 27-8.
3. Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest 2000, 117:1S-4S.
4. Mathers C.D., Boerma T., Ma Fat D. Global and regional causes of death. Br. Med. Bull. 2009, 92:7-32.
5. Sanguinetti C.M. Oxidant/antioxidant imbalance: role in the pathogenesis of COPD. Respiration 1992, 59(Suppl. 1):20-23.
6. Rahman I., Adcock I.M. Oxidative stress and redox regulation of lung inflammation in COPD. Eur. Respir. J. 2006, 28:219-242.
7. Sethi S., Murphy T.F. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 2008, 359:2355-2365.
8. Minematsu N., Blumental-Perry A., Shapiro S.D. Cigarette smoke inhibits engulfment of apoptotic cells by macrophages through inhibition of actin rearrangement. Am. J. Respir. Cell Mol. Biol. 2011, 44:474-482.
9. Richens T.R., et al. Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA. Am. J. Respir. Crit. Care Med. 2009, 179:1011-1021.
10. Hodge S., Hodge G., Ahern J., Jersmann H., Holmes M., Reynolds P.N. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 2007, 37:748-755.
11. Ortega E., Barriga C., Rodriguez A.B. Decline in the phagocytic function of alveolar macrophages from mice exposed to cigarette smoke. Comp. Immunol. Microbiol. Infect. Dis. 1994, 17:77-84.
12. Ortega E., Hueso F., Collazos M.E., Pedrera M.I., Barriga C., Rodriguez A.B. Phagocytosis of latex beads by alveolar macrophages from mice exposed to cigarette smoke. Comp. Immunol. Microbiol. Infect. Dis. 1992, 15:137-142.
13. Knapp S., Leemans J.C., Florquin S., Branger J., Maris N.A., Pater J., van Rooijen N., van der Poll T. Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. Am. J. Respir. Crit. Care Med. 2003, 167:171-179.
14. Shahar E., et al. Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. Atherosclerosis Risk in Communities Study Investigators. N. Engl. J. Med. 1994, 331:228-233.
15. Broekhuizen R., Wouters E.F., Creutzberg E.C., Weling-Scheepers C.A., Schols A.M. Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease. Thorax 2005, 60:376-382.
16. Matsuyama W., Mitsuyama H., Watanabe M., Oonakahara K., Higashimoto I., Osame M., Arimura K. Effects of omega-3 polyunsaturated fatty acids on inflammatory markers in COPD. Chest 2005, 128:3817-3827.
17. Arita M., et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 2005, 201:713-722.
18. Arita M., et al. Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. J. Biol. Chem. 2006, 281:22847-22854.
19. Arita M., Ohira T., Sun Y.P., Elangovan S., Chiang N., Serhan C.N. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J. Immunol. 2007, 178:3912-3917.
20. Ohira T., Arita M., Omori K., Recchiuti A., Van Dyke T.E., Serhan C.N. Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J. Biol. Chem. 2009, 285:3451-3461.
21. Seki H., Tani Y., Arita M. Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1. Prostaglandins Other Lipid Mediat. 2009, 89:126-130.
22. Hasturk H., et al. RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB J. 2006, 20:401-403.
23. Seki, H., et al. The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J. Immunol. 2010;184: 836-843.
24. Suematsu M., Suzuki H., Ishii H., Kato S., Yanagisawa T., Asako H., Suzuki M., Tsuchiya M. Early midzonal oxidative stress preceding cell death in hypoperfused rat liver. Gastroenterology 1992, 103:994-1001.
25. Dunn J.S., Freed B.M., Gustafson D.L., Stringer K.A. Inhibition of human neutrophil reactive oxygen species production and p67phox translocation by cigarette smoke extract. Atherosclerosis 2005, 179:261-267.
26. Yukihiro, M., Hiramatsu, T., Kawano, T. Lethal impacts of cigarette smoke in cultured tobacco cells. Tob. Induc. Dis. 2011;9: 8.
27. Lagente V., Planquois J.M., Leclerc O., Schmidlin F., Bertrand C.P. Oxidative stress is an important component of airway inflammation in mice exposed to cigarette smoke or lipopolysaccharide. Clin. Exp. Pharmacol. Physiol. 2008, 35:601-605.
28. Maestrelli P., El Messlemani A.H., De Fina O., Nowicki Y., Saetta M., Mapp C., Fabbri L.M. Increased expression of heme oxygenase (HO)-1 in alveolar spaces and HO-2 in alveolar walls of smokers. Am. J. Respir. Crit. Care Med. 2001, 164:1508-1513.
29. Park Y.S., Kim J., Misonou Y., Takamiya R., Takahashi M., Freeman M.R., Taniguchi N. Acrolein induces cyclooxygenase-2 and prostaglandin production in human umbilical vein endothelial cells: roles of p38 MAP kinase. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1319-1325.
30. Moretto N., Facchinetti F., Southworth T., Civelli M., Singh D., Patacchini R. alpha,beta-Unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through mitogen-activated protein kinases. Am. J. Physiol. Lung Cell Mol. Physiol. 2009, 296:L839-L848.
31. Kim S.Y., Lee J.H., Huh J.W., Ro J.Y., Oh Y.M., Lee S.D., An S., Lee Y.S. Cigarette smoke induces Akt protein degradation by the ubiquitin-proteasome system. J. Biol. Chem. 2011, 286:31932-31943.
32. Snelgrove R.J., Edwards L., Rae A.J., Hussell T. An absence of reactive oxygen species improves the resolution of lung influenza infection. Eur. J. Immunol. 2006, 36:1364-1373.
33. Vlahos R., Stambas J., Bozinovski S., Broughton B.R., Drummond G.R., Selemidis S. Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation. PLoS Pathog. 2011, 7:e1001271.
34. Banan A., Zhang Y., Losurdo J., Keshavarzian A. Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor alpha in a human colonic cell line. Gut 2000, 46:830-837.
35. Banan A., Fitzpatrick L., Zhang Y., Keshavarzian A. OPC-compounds prevent oxidant-induced carbonylation and depolymerization of the F-actin cytoskeleton and intestinal barrier hyperpermeability. Free Radic. Biol. Med. 2001, 30:287-298.
36. Martin D., Salinas M., Fujita N., Tsuruo T., Cuadrado A. Ceramide and reactive oxygen species generated by H2O2 induce caspase-3-independent degradation of Akt/protein kinase B. J. Biol. Chem. 2002, 277:42943-42952.
37. Bozinovski S., Vlahos R., Hansen M., Liu K., Anderson G.P. Akt in the pathogenesis of COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 2006, 1:31-38.